Drug Database
Back to search

Poland· PL-100342944

Kengrexal

A cangrelor product containing cangrelorum, registered in Poland by Chiesi Farmaceutici S.p.A.. The same ATC class is registered in 13 of our 19 countries.

ATC B01AC25

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedKengrexalATCB01AC25REGISTER NO.PL-100342944PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about cangrelorumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Cangrelor is registered in 13 of 19 countries.

Countries holding a registration under ATC B01AC25 (cangrelor), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 9 of them publish a price we can compare per daily dose
Search cangrelor products by name

Cangrelor · ATC B01AC25

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Cangrelorum
Manufacturer
Chiesi Farmaceutici S.p.A.
Country
Poland (PL)
ATC code
B01AC25
ATC class
Cangrelor
Defined daily dose
50 mg, P
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    08025153012580

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

135 interactions on record for cangrelor.

Graded by severity as the source publishes them — 65 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check cangrelor against other medicinesHow interaction checks work

Cangrelor · interactions on record

135 records

  • 65 severe
  • 70 moderate

Most severe, free to view

  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • HeparinB01AB01severe
  • Antithrombin IIIB01AB02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cangrelor in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cangrelor products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/02b729fd-0e38-4ba2-8858-d14e1c82979d
GET /v1/drugs/02b729fd-0e38-4ba2-8858-d14e1c82979d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Proszek do sporządzania koncentratu roztworu do wstrzykiwań lub infuzji",
  "source": "urpl",
  "strength": "50 mg",
  "packaging": "08025153012580 ¦ Rpz ¦ EU/1/15/994/001 ¦ 108197\n10 fiol. 10 ml",
  "substance": "Cangrelori tetranatricum 50 mg",
  "common_name": "Cangrelorum",
  "pl_product_id": "100342944",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}
API referenceMCP serverPlans

See everything about cangrelor.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console